glp-1 receptor agonist market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Agonists Weight Loss Drugs

Research progress on drugs for diabetes based on insulin receptor/insulin receptor substrate

It helps regulate insulin and glucagon for blood sugar control, the rate at which food moves through the digestive tract, and your fullness after a meal or snack

Journal of Functional Foods 2017;38A:180-96.

Recognized for their multifunctional bioactivity, phenolic compounds are extensively distributed throughout the plant kingdom

doi:10.1007/BF02284971

In summary, reconciling all discussed aspects relevant to insulin, IGF-1 improves insulin sensitivity by suppressing insulin and GH secretion and by improving insulin signalling indirectly reducing FFA flux